| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.3 | 5e-14 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-12 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-09 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-07 |